Blog
RSS FeedPosted by Michael Wonder on 20 Aug 2021
Recommendations made by the PBAC – July 2021
20 August 2021 - Recommendations made by the PBAC in July 2021 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 17 Aug 2021
Final terms of reference and public consultation to the post-market review of opiate dependence treatment program medicines
17 August 2021 - The public consultation process for the post-market review of opiate dependence treatment program medicines is now ...
Posted by Michael Wonder on 15 Aug 2021
Australia secures one million Pfizer doses from Poland, with more than half destined for Sydney
15 August 2021 - Poland has come to Australia’s rescue with an extra one million Pfizer doses after the government went ...
Posted by Michael Wonder on 13 Aug 2021
PBS arrangements for tocilizumab shortage
13 August 2021 - The sponsor of tocilizumab (Actemra) Roche has notified the TGA of shortages of multiple presentations of tocilizumab ...
Posted by Michael Wonder on 12 Aug 2021
Drug shortages putting patients at risk
12 August 2021 - Pharmacists are reporting critical shortages in heart and stroke medications, mental health drugs and HRT therapies ...
Posted by Michael Wonder on 09 Aug 2021
Version 4 and counting
9 August 2021 - The Department of Health has published yet another revised agenda for the November 2021 PBAC meeting. ...
Posted by Michael Wonder on 06 Aug 2021
Updated financial estimates workbook
6 August 2021 - An updated version of the Utilisation and Cost Model workbook is now available to support PBAC submissions. ...
Posted by Michael Wonder on 03 Aug 2021
DoH publishes revised agenda for Nov 2021 PBAC meeting
3 August 2021 - One week on and we are already up to version 3. ...
Posted by Michael Wonder on 03 Aug 2021
National Medicines Policy Review Committee and Terms of Reference
3 August 2021 - The National Medicines Policy has influenced a number of important strategies, frameworks and programs developed since ...
Posted by Michael Wonder on 02 Aug 2021
Government subsidises medicine to combat high cholesterol in ‘high-risk’ Australians
1 August 2021 - Experts are welcoming the PBS listing of a medicine that helps reduce unacceptably high ‘bad cholesterol’ ...
Posted by Michael Wonder on 02 Aug 2021
National Medicines Policy Review will be significant for all Australians
30 July 2021 - Medicines Australia is eager to be part of a significant moment in history for Australian health ...
Posted by Michael Wonder on 02 Aug 2021
Reducing the cost of medicines through new PBS listings
1 August 2021 - From August 1, the Australian Government is listing a number of new medicines on the PBS to ...
Posted by Michael Wonder on 01 Aug 2021
Muscular atrophy, cholesterol and migraine medications added to PBS
1 August 2021 - Australians living with chronic health conditions will save up to $123,000 per year with the addition ...
Posted by Michael Wonder on 31 Jul 2021
New migraine, spinal muscular atrophy drugs on PBS ease financial pain
1 August 2021 - New drugs for spinal muscular atrophy, migraine and high cholesterol are being added to the pharmaceutical ...
Posted by Michael Wonder on 31 Jul 2021
Schedule of Pharmaceutical Benefits - 1 August 2021
1 August 2021 - The August 2021 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...